Cholestyramine Use in Bile Acid Diarrhea

Introduction to Cholestyramine

Cholestyramine can potentially inhibit lipase activity and worsen fat absorption, particularly in patients with severe bile acid malabsorption, though this effect is minimal in most patients with mild to moderate bile acid diarrhea 1
The American Gastroenterological Association notes that cholestyramine is a bile acid sequestrant (BAS) that works by binding bile acids in the intestine, preventing their reabsorption, which has several consequences related to lipase activity and fat absorption 1

In patients with mild cases of bile acid diarrhea, cholestyramine has minimal additional risk of fat malabsorption 1
In severe cases of bile acid malabsorption, steatorrhea may worsen as a result of cholestyramine treatment 1
The European Society for Clinical Nutrition and Metabolism suggests that by binding bile acids, cholestyramine reduces the bile acid pool available for fat digestion, which can theoretically lead to reduced fat absorption, especially in patients with already compromised pancreatic function 1

In patients with short bowel and significant ileal resection, cholestyramine may help control diarrhea but has the additional disadvantage of reducing oxalate absorption 2
The National Institute of Diabetes and Digestive and Kidney Diseases notes that by further reducing the bile salt pool, cholestyramine will increase fat malabsorption 2
For patients with pancreatic exocrine insufficiency who already have compromised lipase activity, adding cholestyramine could theoretically exacerbate fat malabsorption, and the American College of Gastroenterology recommends pancreatic enzyme replacement therapy (PERT) as the gold standard treatment for pancreatic exocrine insufficiency 3

The effect of cholestyramine on fat absorption appears to be dose-dependent, with standard doses ranging from 4-16g/day depending on the indication 1, 4, 5
The American College of Cardiology suggests that when cholestyramine is used long-term, monitoring for potential consequences of fat malabsorption may be warranted, including fat-soluble vitamin deficiencies (A, D, E, K) and prothrombin time/INR monitoring 4

For patients with mild to moderate bile acid diarrhea, standard cholestyramine treatment can be used with minimal concern for significant fat malabsorption 1
For patients with severe bile acid malabsorption, monitor for worsening steatorrhea after initiating cholestyramine, and consider lower doses or alternative bile acid sequestrants if fat malabsorption worsens 1
For patients with pre-existing fat malabsorption, use cholestyramine cautiously, as it may exacerbate the condition, and consider monitoring fat-soluble vitamin levels if long-term therapy is planned 4

Administer other medications at least 1 hour before or 4-6 hours after cholestyramine to avoid binding and reduced absorption, particularly for fat-soluble medications 4